Agenda.
- Agenda -
Thursday 11th May 2023
Chairs:
Mr Frank O’Brien, Cork University Hospital & Dr Richard Bambury, Cork University Hospital
1250 - 1300
The Patient Journey
Martin Sweeney
Patient Advocate
1300 - 1320
Men with Prostate Cancer & Their Needs
Prof Suzanne Chambers
Australian Catholic University, Brisbane
1320 - 1340
Evolving Role For Biomarkers and Imaging After Prostate Cancer Diagnosis
Prof Matt Cooperberg
University of California, San Francisco
1340 - 1400
Radiation Oncology - Perspective on TMT in Bladder Cancer
Dr Sophia Kamran
Harvard Medical School
1400 - 1420
Pathology- Molecular Aspects of Urothelial Carcinoma
Dr Priti Lal
University of Pennsylvania
1420 - 1440
Gleason 6 Prostate Cancer- Time To Stop Calling It Cancer?
Prof Scott Eggener
University of Chicago
1440 - 1500
Adjuvant Treatment for Renal Cell Carcinoma – Are Immune Checkpoint Inhibitors the Answer?
Dr Jack Gleeson
Cork University Hospital.
1500 - 1530
Panel Discussion - Prostate
1530 - 1600
Coffee Break
Chairs:
Ms Louise McLoughlin, St James’s Hospital, Dublin & Dr Richard Moore, Mater Private Hospital, Dublin
1600 - 1620
The Search for Biomarkers to Predict Immunotherapy Response in Renal Cell Carcinoma
Dr Yasser Ged
John Hopkins Hospital, Baltimore
1620 – 1640
Artificial Intelligence in Bladder Cancer
Prof Girish Kulkarni
Princess Margaret Cancer Center, Toronto
1640 - 1700
The Surgical Management of High Risk Prostate Cancer
Prof Prasanna Sooriakumaran
Cleveland Clinic, London
1700 - 1720
Radiation - High Risk Prostate Cancer
Prof Paul Nguyen
Dana-Farber Cancer Institute, Boston
1720 - 1740
Royal College of Surgeons of Edinburgh King James IV Professorship Lecture - Screening for Kidney Cancer, Near Reality or Pipe Dream
Prof Grant Stewart
University Of Cambridge
1740 - 1800
Is Robot Assisted Radical Cystectomy The Standard Of Care?
Prof John Kelly
University College London
1800 – 1830
Panel Discussion- Bladder
1830
End of Day 1
Friday 12th May 2023
Chairs:
Mr Peter Lonergan St James’s Hospital, Dublin & Dr Nick Mayer, Cork University Hospital
0830 - 0850
Is it Feasible or Rational to Restrict PSMA-PET Scans for Men with Prostate Cancer?
Mr Thomas Walton
Nottingham University Hospitals
0850 - 0900
Update on Irish Use of Lutetium PSMA
Martin O’Connell
Mater Misericordiae University Hospital, Dublin
0900 - 0920
The Subtypes of Bladder Tumours
Dr Priti Lal
University of Pennsylvania
0920- 0940
Update on Active Surveillance for Prostate Cancer
Prof Matt Cooperberg
University of California, San Francisco
0940 - 1000
Peri-operative Systemic Therapy for Urothelial Carcinoma – State of the Art and Future Avenues
Prof Alison Birtle
Lancashire Teaching Hospitals
1000 - 1020
Development and Validation of a Novel Six-Gene Signature to Predict Aggressive Prostate Cancer
Prof Liam Gallagher
University College Dublin
1020 - 1100
Coffee Break
Chairs:
Ms Catherine Dowling, University Hospital Galway & Prof Joe O’ Sullivan, Queen’s University Belfast
1100 –1110
The Patient Journey
Brian Egan
Patient Advocate
1110 - 1130
Post Prostatectomy Radiation/Salvage Radiation in PSMA Era/strong>
Prof Paul Nguyen
Dana-Farber Cancer Institute, Boston
1130 - 1150
IPCOR Study 2023
Mr David Galvin
IPCOR
1150 - 1210
Emotional Toll of Surgical Complications
Prof Scott Eggener
University of Chicago
1210 - 1230
The ANP Role in Non- Muscle Invasive Bladder Cancer
Mr Robert McConkey
University Hospital Galway
1230 - 1250
Novel and Emerging Therapeutic Strategies for Prostate Cancer
Dr Lynda Corrigan
Tallaght University Hospital
1250– 1310
Neoadjuvant Treatment of Kidney Cancer - Why, What and How
Prof Grant Stewart
University Of Cambridge
1310 - 1400
Lunch
Chairs:
Mr Niall Davis, Beaumont Hospital, Dublin & Dr Adrian Murphy, Beaumont Hospital, Dublin
1400 - 1420
Radiation Oncology-The role of SBRT in Renal Oligometastases
Dr Sophia Kamran
Harvard Medical School
1420 - 1440
Living Well With and Beyond Cancer and the Future
Prof Suzanne Chambers
Australian Catholic University, Brisbane
1440- 1500
Molecular Characteristics of Metastatic Urothelial Carcinoma
Dr Min Yuen Teo
MSKCC, New York
1500 - 1520
Future Perspectives in the Management of Localised Kidney Cancer
Mr Thomas Walton
Nottingham University Hospitals
1520 - 1540
Updates in High Risk Non-Muscle Invasive Bladder Cancer
Prof Girish Kulkarni
Princess Margaret Cancer Center, Toronto
1540 – 1615
Panel Discussion- Renal
1615
End of Proceedings